Insider Transactions in Q3 2024 at Immunovant, Inc. (IMVT)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 21
2024
|
Mark S. Levine Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
3,295
-0.49%
|
$105,440
$32.08 P/Share
|
|
Aug 21
2024
|
Julia G. Butchko Chief Development Officer |
SELL
Open market or private sale
|
Direct |
3,027
-0.34%
|
$96,864
$32.08 P/Share
|
|
Aug 21
2024
|
Eva Renee Barnett Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,768
-0.54%
|
$120,576
$32.08 P/Share
|
|
Aug 21
2024
|
William L. Macias Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,027
-0.41%
|
$96,864
$32.08 P/Share
|
|
Aug 21
2024
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
15,068
-0.74%
|
$482,176
$32.08 P/Share
|
|
Jul 24
2024
|
Michael Geffner Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,456
-2.44%
|
$93,312
$27.76 P/Share
|
|
Jul 24
2024
|
Jay S Stout Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
2,813
-1.9%
|
$75,951
$27.76 P/Share
|
|
Jul 24
2024
|
Mark S. Levine Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,015
-1.19%
|
$108,405
$27.76 P/Share
|
|
Jul 17
2024
|
Eva Renee Barnett Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,123
-0.45%
|
$93,690
$30.09 P/Share
|
|
Jul 17
2024
|
William L. Macias Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,044
-0.2%
|
$91,320
$30.09 P/Share
|
|
Jul 17
2024
|
Mark S. Levine Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,505
-0.37%
|
$75,150
$30.09 P/Share
|
|
Jul 17
2024
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
8,685
-0.42%
|
$260,550
$30.09 P/Share
|
|
Jul 17
2024
|
Julia G. Butchko Chief Development Officer |
SELL
Open market or private sale
|
Direct |
2,867
-0.32%
|
$86,010
$30.09 P/Share
|
|
Jul 09
2024
|
Peter Salzmann Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
4,619
-0.45%
|
$129,332
$28.06 P/Share
|
|
Jul 09
2024
|
Julia G. Butchko Chief Development Officer |
SELL
Open market or private sale
|
Direct |
1,527
-0.34%
|
$42,756
$28.06 P/Share
|
|
Jul 09
2024
|
Eva Renee Barnett Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
4,747
-1.34%
|
$132,916
$28.06 P/Share
|